Background Polyploidy is a prominent feature of many human cancers, and it has long been hypothesized that polyploidy may contribute to tumorigenesis by promoting genomic instability. In this study, we investigated whether polyploidy per se induced by a relevant oncogene can promote genomic instability and tumorigenicity in human epithelial cells. Principal Findings When the oncogenic serine-threonine kinase Pim-1 is overexpressed in immortalized, non-tumorigenic human prostate and mammary epithelial cells, these cells gradually converted to polyploidy and became tumorigenic. To assess the contribution of polyploidy to tumorigenicity, we obtained sorted, matched populations of diploid and polyploid cells expressing equivalent levels of the Pim-1 protein. Spectral karyotyping revealed evidence of emerging numerical and structural chromosomal abnormalities in polyploid cells, supporting the proposition that polyploidy promotes chromosomal instability. Polyploid cells displayed an intact p53/p21 pathway, indicating that the viability of polyploid cells in this system is not dependent on the inactivation of the p53 signaling pathway. Remarkably, only the sorted polyploid cells were tumorigenic in vitro and in vivo. Conclusions Our results support the notion that polyploidy can promote chromosomal instability and the initiation of tumorigenesis in human epithelial cells.
References
[1]
Cahill DP, Kinzler KW, Vogelstein B, Lengauer C (1999) Genetic instability and darwinian selection in tumours. Trends Cell Biol 9: M57–60.
[2]
Duesberg P (2005) Does aneuploidy or mutation start cancer? Science 307: 41.
[3]
Ganem NJ, Storchova Z, Pellman D (2007) Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17: 57–162.
[4]
Ganem NJ, Pellman D (2007) Limiting the proliferation of polyploid cells. Cell 131: 437–440.
[5]
Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25: 195–204.
[6]
Duensing S, Munger K (2003) Centrosomes, genomic instability, and cervical carcinogenesis. Crit Rev Eukaryot Gene Expr 13: 9–23.
[7]
Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, et al. (2006) Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27: 337–343.
[8]
Ai H, Barrera JE, Meyers AD, Shroyer KR, Varella-Garcia M (2001) Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions. Laryngoscope 111: 1853–1858.
[9]
Cardoso J, Molenaar L, de Menezes RX, van Leerdam M, Rosenberg C, et al. (2006) Chromosomal instability in MYH- and APC-mutant adenomatous polyps. Cancer Res 66: 2514–2519.
[10]
Doak SH, Jenkins GJ, Parry EM, Griffiths AP, Baxter JN, et al. (2004) Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression. Mutat Res 547: 133–144.
[11]
Pihan GA, Wallace J, Zhou Y, Doxsey SJ (2003) Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63: 398–1404.
[12]
Marx J (2002) Debate surges over the origins of genomic defects in cancer. Science 297: 44–546.
[13]
Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, et al. (2005) Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437: 1043–1047.
[14]
Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW (2007) Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25–36.
[15]
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, et al. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822–826.
[16]
Valdman A, Fang X, Pang ST, Ekman P, Egevad L (2004) Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer. Prostate 60: 367–371.
[17]
Bachmann M, Moroy T (2005) The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 37: 726–730.
[18]
Roh M, Gary B, Song C, Said-Al-Naief N, Tousson A, et al. (2003) Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Cancer Res 63: 8079–8084.
[19]
Roh M, Song C, Kim J, Abdulkadir SA (2005) Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1. J Biol Chem 280: 40568–40577.
[20]
Jung YJ, Chae HC, Seoh JY, Ryu KH, Park HK, et al. (2007) Pim-1 induced polyploidy but did not affect megakaryocytic differentiation of K562 cells and CD34+ cells from cord blood. Eur J Haematol 78: 131–138.
[21]
Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A (1999) The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 18: 4022–4031.
[22]
Uetake Y, Sluder G (2004) Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a “tetraploidy checkpoint”. J Cell Biol 165: 09–615.
[23]
Thomas M, Massimi P, Banks L (1996) HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence. Oncogene 13: 471–480.
[24]
Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, et al. (1995) Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10: 927–936.
[25]
Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier HU, et al. (1998) Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 63: 131–140.
[26]
Duesberg P, Li R (2003) Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2: 202–210.
[27]
Forsslund G, Zetterberg A (1990) Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Cancer Res 50: 4281–4285.
[28]
Deitch AD, Miller GJ, deVere White RW (1993) Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue. Cancer 72: 1692–1700.
[29]
Mendelin J, Grayson M, Wallis T, Visscher DW (1999) Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Lab Invest 79: 387–393.
[30]
Visscher DW, Wallis TL, Crissman JD (1996) Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer 77: 315–320.
[31]
Ottesen GL, Christensen IJ, Larsen JK, Kerndrup GB, Hansen B, et al. (1995) DNA aneuploidy in early breast cancer. Br J Cancer 72: 832–839.
[32]
Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, et al. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50–65.
[33]
Woo RA, Poon RY (2004) Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev 18: 317–1330.
[34]
Li Q, Dang CV (1999) c-Myc overexpression uncouples DNA replication from mitosis. Mol Cell Biol 19: 5339–5351.
[35]
Dikovskaya D, Schiffmann D, Newton IP, Oakley A, Kroboth K, et al. (2007) Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol 176: 83–195.
[36]
Caldwell CM, Green RA, Kaplan KB (2007) APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J Cell Biol 178: 109–1120.
[37]
Sagulenko E, Savelyeva L, Ehemann V, Sagulenko V, Hofmann W, et al. (2007) Suppression of polyploidy by the BRCA2 protein. Cancer Lett 257: 65–72.
[38]
Wang X, Zhou YX, Qiao W, Tominaga Y, Ouchi M, et al. (2006) Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25: 148–7158.
[39]
Yin XY, Grove L, Datta NS, Long MW, Prochownik EV (1999) C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18: 177–1184.
[40]
Minn AJ, Boise LH, Thompson CB (1996) Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10: 2621–2631.
[41]
Andreassen PR, Lohez OD, Lacroix FB, Margolis RL (2001) Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12: 315–1328.
[42]
Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, et al. (2006) Apoptosis regulation in tetraploid cancer cells. Embo J 25: 2584–2595.
[43]
Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, et al. (2004) Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett 571: 43–49.
[44]
Li R, Sonik A, Stindl R, Rasnick D, Duesberg P (2000) Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A 97: 236–3241.
[45]
Abdulkadir SA, Qu Z, Garabedian E, Song SK, Peters TJ, et al. (2001) Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med 7: 101–107.
[46]
Mogal AP, van der Meer R, Crooke PS, Abdulkadir SA (2007) Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation. J Biol Chem 282: 25790–25800.
[47]
Karpf AR, Matsui S (2005) Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 65: 635–8639.
